Neolife SAS

As of December 31, 2024, Neolife SAS carries a market capitalization of 5.96M, placing it among publicly traded companies globally. Its enterprise value stands at 5.51M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2024, Neolife SAS has 96.37M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Neolife SAS maintains a current ratio of 1.72, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

As of the close on October 23, 2026, Neolife SAS's stock has declined approximately 4.51% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.06.

As of December 31, 2024, Neolife SAS holds 1.87M in cash and equivalents against 1.42M in total debt, resulting in a net debt position of -317,065.00. Total book value stands at 4.94M, with working capital of 2.17M providing operational flexibility.

Neolife SAS's most recent stock split took place on August 13, 2015.